Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Omega Therapeutics, Inc. Common Stock (OMGA)

Biological Products, (no Disgnostic Substances)

https://www.omegatherapeutics.com

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. It primarily operates in the U.S.

140 FIRST STREET, SUITE 501
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

84,387,150

Shares Outstanding

55,140,000

Weighted SO

55,141,838

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

PMVP --.--%

ELYM --.--%

MNOV --.--%

PHVS --.--%

PEPG --.--%

OLMA --.--%

NVCT --.--%

LRMR --.--%

CNTA --.--%

Beta

1.9010

Last Div

0.0000

Range

1.3-6.3

Chg

0.0001

Avg Vol

455559

Mkt Cap

84387150

Exch

NASDAQ

Country

US

Phone

617 949 4360

DCF Diff

6.9006

DCF

-3.2506

Div Yield

0.0000

P/S

13.3651

EV Multiple

-2.1609

P/FV

3.2130

Div Yield %

0.0000

P/E

-1.0695

PEG

-0.0287

Payout

0.0000

Current Ratio

2.1948

Quick Ratio

2.1948

Cash Ratio

1.8084

DSO

43.5295

DIO

0.0000

Op Cycle

43.5295

DPO

103.2384

CCC

-59.7089

Gross Margin

0.0380

Op Margin

-12.7705

Pretax Margin

-12.4954

Net Margin

-12.4954

Eff Tax Rate

-0.0501

ROA

-0.4690

ROE

-1.5648

ROCE

-0.5651

NI/EBT

1.0000

EBT/EBIT

0.9785

EBIT/Rev

-12.7705

Debt Ratio

0.1708

D/E

1.0942

LT Debt/Cap

0.3296

Total Debt/Cap

0.5225

Int Coverage

49.1965

CF/Debt

-2.2481

Equity Multi

6.4056

Rec Turnover

8.3851

Pay Turnover

3.5355

Inv Turnover

0.0000

FA Turnover

0.0563

Asset Turnover

0.0375

OCF/Share

-1.1714

FCF/Share

-1.2216

Cash/Share

0.8376

OCF/Sales

-10.2319

FCF/OCF

1.0428

CF Coverage

-2.2481

ST Coverage

-4.0816

CapEx Coverage

-23.3565

Div&CapEx Cov

-23.3565

P/BV

3.2130

P/B

3.2130

P/S

13.3651

P/E

-1.0695

P/FCF

-1.2526

P/OCF

-1.3061

P/CF

-1.3061

PEG

-0.0287

P/S

13.3651

EV Multiple

-2.1609

P/FV

3.2130

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks The Motley Fool Jan 04, 18:08 Why Novo Nordisk Stock Crushed the Market Today MarketWatch Jan 04, 10:57 Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact MarketWatch Jan 04, 08:34 HSBC warns another ‘reverse Goldilocks’ may soon hit stocks and junk bonds MarketWatch Jan 04, 07:55 HSBC warns another ‘reverse Goldilocks’ may soon hit stocks and junk bonds MarketWatch Jan 04, 07:42 Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Revenue Product Segmentation